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INTRODUCTION
The invention of Induced Pluripotent Stem Cell (iPSC) technology opened a new era for patient-specific personalized medicine (1). iPSCs are also the most important potential source of human cardiomyocytes for basic research, drug screening, disease modeling, and regenerative medicine (1, 2). iPSCs closely resemble human embryonic stem cells (hESCs) in terms of their morphology and differentiation ability into cells of the three germ layers, yet their use poses less ethical concerns than hESCs. Many somatic cell types have been successfully reprogrammed into iPSCs by expression of four exogenous transcription factors (i.e., Oct3/4, Sox-2, c-Myc, and Klf4), including skin fibroblasts, blood cells, keratinocytes, bone marrow mesenchymal stem cells, adipose stromal cells, hair follicles, and dental pulp cells (3) (4) (5) (6) (7) (8) (9) . Although early reports suggests that iPSCs display epigenetic and transcriptional similarities to hESCs, recent evidence indicates that iPSCs can retain a memory of their tissue of origin, such as preserving the DNA methylation signature typical of their donor cells particularly at early cell passages after pluripotency induction (5, 10) .
Researchers have successfully reprogrammed neonatal murine cardiomyocytes (CMs) and human Sca-1 positive cardiac progenitors to iPSCs, which displayed a higher propensity to re-differentiate into CMs than iPSCs derived from syngeneic cardiac, tail and skin fibroblasts (11-13). Nevertheless, no one has to date demonstrated that fibroblasts from different tissues can generate iPSCs with specific differentiation ability. We recently showed that, compared to stromal cells derived from bone marrow, cardiac stromal cells (CStCs), even in their original state, exhibited higher expression of cardiac mesoderm-related genes and had a higher propensity to differentiate towards the myocardial lineage both in vitro and in vivo (14) . Here, we find that at passages greater than 15, iPSCs derived from human CStCs, when compared to iPSCs derived from syngeneic skin stromal cells (SStCs), retain a differentiation memory of their founder organ, showing higher ability to generate cardiomyocytes although deriving from the stromal component of the tissue and not from the parenchyma. Of note, we also found a subset of microRNAs that, being differentially modulated in cardiac vs skin stromal cells during the pluripotency induction process, can be potentially associated with the epigenetic regulation of higher cardiogenic potentials of iPSCs from CStCs vs SStCs.
MATERIALS AND METHODS
Ethics statement
Human fetal skin (SStC) and cardiac (CStC) stromal cells were isolated from discarded right atrial tissues and skin of the same aborted fetuses of healthy pregnant women after signed informed consent from University of California-San Diego and iPSCs were generated at the Sanford Burnham Medical Research Institute. Approved research protocols from respective Institutional Review Boards or Institute Ethical committee at each institution were obtained prior to this study. Experiments were conducted in accordance to the principles expressed in the Declaration of Helsinki. All data were collected and analyzed anonymously.
Isolation and culture of skin and cardiac fetal stromal cells
Briefly, heart and skin tissues were minced into small pieces (size between 2-4 mm 2 ) and digested with 0.25 percent of trypsin-EDTA for 5 minutes at 37°C. After digestion, the supernatant was discarded and the tissue pieces were placed on culture dishes in standard growth medium (GM), composed of Iscove's Modified Dulbecco's Medium (IMDM, Lonza) supplemented with 20 percent of fetal bovine serum (FBS, Hyclone), 10 ng/ml basic Fibroblast Growth Factor (bFGF, R&D System), 10,000 U/ml Penicillin/Streptomycin (Invitrogen), 20 mM L-Glutamine (Sigma-Aldrich). Fibroblasts started to migrate out of the explants in 7-10 days and reach 90 percent of confluence in 2-3 weeks. The stromal cell population was sub-selected by culturing fibroblasts on the plastic surface of a 12-well plate for 30-60 minutes and only the most adhesive cells were retained for further passages and subsequent characterization.
Flow cytometry
Cells were detached with 0.02 percent of EDTA solution (Sigma-Aldrich) and incubated with FITC/PE/ © 1996-2016 APC conjugated primary antibodies for 10 minutes at room temperature. The following antibodies were used: CD13, CD14, CD29, CD31, CD34, CD44, CD45, CD73, CD90, CD117, HLA-ABC, HLA-DR, Chondroitin sulfate and Nestin (BD Biosciences); VEGFR2, CD105, CD144 and CD146 (R&D Systems). Embryoid bodies and dissected beating areas were dissociated at single cell level with TrypLE for 10 minutes at 37°C and then fixed and permeabilized using BD Cytofix/Cytoperm (BD Biosciences), following the manufacturer's instructions. Cells were incubated with a primary antibody against Troponin-T (Tn-T, Abcam) for 30 minutes at 4°C and then with an APC-conjugated secondary antibody (Abcam) for 30 minutes at 4°C. Cells were incubated with the corresponding IgG isotype, conjugated with the same fluorochrome used for the primary antibody. Cells were analyzed using a FACSCalibur flow cytometer (BD Biosciences) equipped with Cell-Quest Software v2.4.
Evaluation of fetal cell plasticity towards the cardiovascular lineages
SStCs and CStCs were plated at a density of 5000 cells/cm 2 and exposed to the appropriate medium.
The medium was changed twice a week. Cells were then analyzed for the acquisition of lineage-specific properties. Specifically, the appearance of cardiac precursor phenotype was assessed after a 7 daytreatment with an Epigenetic cocktail (EpiC) containing 5 mM all-trans retinoic acid (ATRA), 5 mM phenyl butyrate (PB), and 200 mM diethylenetriamine/nitric oxide (DETA/NO) (15, 16).
Western blot
SStCs and CStCs were lysed with Laemmli buffer containing phosphatase inhibitors (Roche). Total proteins were resolved by SDS-PAGE and transferred onto nitrocellulose membrane (Bio-Rad). Membranes were incubated overnight at 4°C with primary antibodies (Table 1) and then 1 hour at room temperature with the appropriate HRP-conjugated secondary antibody (Amersham-GE Healthcare). Each membrane was also probed with anti-beta-tubulin or anti-GAPDH to verify equal protein loading. Chemiluminescence detection was performed using ECL (Amersham-GE Healthcare). Densitometric analyses were performed using the NIH ImageJ software v1.43.67.
Generation and culture of iPSCs
IPSCs from SStCs and CStCs were generated using an integration-free episomal method as previously described, using pCXLE-EGFP, pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL (Addgene) as episomal vectors (17, 18) . Briefly, fetal StCs were electroporated using a Neon System (Invitrogen) with 1 microgram for each episomal vector and then plated onto a plastic tissue culture dish. Six days after the electroporation, transfected fibroblasts were trypsinized and plated onto Matrigel-coated dishes containing an irradiated mouse embryonic fibroblast (MEF) feeder layer in GM. One day later, the medium was changed to stem cell medium containing: knockout KO-DMEM (Gibco), 20 percent of KO-Serum Replacement (KOSR, Gibco), 1 mM NEAAs (Gibco), 10,000 U/ml Penicillin/Streptomycin (Invitrogen), 20 mM L-Glutamine (Sigma-Aldrich), 0.1 mM beta-mercaptoethanol (Gibco), and 10 ng/ml bFGF (R&D System). iPSC colonies were selected based on stem cell-like morphology at 18-20 days after transfection and expanded after manual micro-dissection by plating on Matrigel-coated dishes containing a MEF feeder layer.
Alkaline phosphatase assay
The expression of alkaline phosphatase was evaluated using the Alkaline Phosphatase Staining Kit (Stemgent), according to manufacturer's instructions.
Immunofluorescence
Cells were fixed with 4 percent of PFA for 10 minutes and permeabilized with 0.2 percent of Triton-100X (Sigma-Aldrich); then a blocking buffer (5% BSA in PBS) was added for 1 hour at room temperature. Primary antibodies for selected markers (Table 1) diluted in blocking buffer were added overnight at 4°C. 
Cardiomyogenic differentiation
The cardiomyogenic differentiation protocol for iPSCs was performed as previously described (18, 19) . Cardiomyogenic differentiation experiments were performed using three independent iPSC lines. In brief, iPSCs were differentiated as embryoid bodies (EBs) by detaching colonies from the MEF feeder using 1 mg/ml Collagenase IV (Gibco) for 5 minutes at 37 °C. EBs were maintained for six days in suspension culture in ultra-low attachment plates in EB media, composed of: KO-DMEM (Gibco) with 20 percent of FBS (Hyclone), 1 mM NEAAs (Gibco), 10,000 U/ml Penicillin/Streptomycin (Invitrogen), 20 mM L-Glutamine (Sigma-Aldrich), and 0.1 mM beta-mercaptoethanol (Gibco). At day 7, EBs were plated onto gelatin-coated dishes for better detection of beating foci. Beating clusters usually appeared at 10-12 days from the beginning of the differentiation protocol. Approximately at day 25 of EB differentiation, beating areas were manually microdissected to enrich the cardiomyocyte population, plated onto gelatin-coated plates, maintained in the same EB medium except for supplementation with only 2 percent of FBS (to avoid fibroblast over-growth) and used at day 30 and day 60 for RT-qPCR, immunofluorescence and electrophysiology analyses.
Electrophysiology
Electrophysiology recordings were performed on dissected spontaneously beating bodies as previously described with minor modifications (20) . Spontaneously beating areas were manually dissected from the EBs and plated in 35 mm dishes with 0.1 percent of gelatin. After few days, necessary for the adhesion to the plate, the dishes were placed on the stage of an inverted microscope and superfused with a Tyrode solution pH 7.4 containing: 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 5.5 mM D-glucose, and 5 mM Hepes-NaOH. Spontaneous action potentials were recorded from whole beating areas by the patch-clamp technique in current clamp mode using a whole-cell configuration. The patch pipette had a resistance of 5-8 MΩ when filled with the intracellular-like solution pH 7.2 containing: 130 mM K-aspartate, 10 mM NaCl, 5 mM EGTA-KOH, 2 mM CaCl 2 , 2 mM MgCl 2 , 2 mM ATP (Na-salt), 5 mM phosphocreatine, 0.1 mM GTP (Na-salt), and 10 mM Hepes-KOH. Temperature was kept at 36±1 °C. Isoproterenol (1 microM) was added to the Tyrode solution from a concentrated stock. Beating rates, maximum diastolic potential (MDP) and action potential amplitude were analyzed using Clampfit and Origin v9.0 software.
Evaluation of cardiac contraction parameters
In order to compare C-iPSCs and S-iPSCs, beating areas from the kinematic and dynamic perspective, evaluations of contractility (maximum velocity of contraction propagation within the beating areas), and contraction frequency were carried out as previously described (21) . Briefly, video observations of 30 seconds were recorded by a CCD camera at 16 frames per second (Cool SnapTM EZ Photometrics). After that, the Video Spot Tracker (VST) program was used to track the motion of one or more spots in a video (http://cismm.cs.unc.edu/downloads). In each video, 4 spots or markers were systematically selected onto the first video frame. By starting the videos in VST, frame by frame, the program followed and registered the spatialtemporal coordinates x, y, and t for each marker. The coordinates x and y were expressed in (pixel), whereas the coordinate t in seconds (s). Moreover, using an algorithm based on the Matlab programming language (The MathWorks, Inc., Natick, MA), frame by frame and for each marker, kinematics and dynamics of the beating syncytia were studied, as previously described (21) . The statistical differences between the observed measures were tested via Kruskal-Wallis test, followed by DunnSidák correction, electing a significance level of 0.05; the results were expressed as median with 25 th and 75 th percentiles.
Real-time reverse transcriptionpolymerase chain reaction (RT-qPCR) analysis
Total RNA was extracted from StCs, iPSCs and EBs using TRIzol reagent (Invitrogen) following the manufacturer's instructions. Total RNA concentration and purity were evaluated by a NanoDrop 1000 spectrophotometer (Thermo Scientific), while RNA integrity was assessed with an Experion electrophoresis system using the RNA High Sense Analysis Kit (Bio-Rad). Only high quality RNAs, with A260/A280 and A260/A230 ratios > 1.8 and a RQI > 9.5, were used for subsequent investigations. 1 microgram of total RNA was reverse transcribed using Superscript III First-Strand Synthesis SuperMix (Invitrogen). cDNA was amplified by SYBR-GREEN quantitative PCR on an iQ5 Cycler (Bio-Rad). Primer sequences for all the genes tested are reported in Table 2 . Individual miR expression was analyzed by using specific single-assay miR primers (Applied Biosystems). Assays used were for hsa-miR-1, hsa-miR-133a, hsamiR-133b, hsa-miR-208, and U6 snRNA. Reversetranscription and real-time PCR reactions were performed according to the manufacturer's instructions, using a 7900TH Real-Time PCR System (Applied Biosystems). Raw expression intensities were normalized using the Ct value of GAPDH and U6 snRNA, for genes and miRs respectively. A Ct value=40 was arbitrarily assigned to unexpressed genes/miRs. Relative quantitation was performed using the ∆∆Ct method. Fold changes in gene expression were estimated as 2 (-∆∆Ct) (22) . © 1996-2016
MicroRNA profiling
Comparative microRNA (miR) expression profiling was carried out using TaqMan Low Density Arrays for the Human MicroRNA A and B Card Sets v3.0 (Applied Biosystems), according to the manufacturer's instructions, using a 7900TH Real-Time PCR System (Applied Biosystems). Prior to the analysis, probes were renamed and reannotated according to miRBase Release 20 (http://www.mirbase.org) (23) . This allowed us to identify target sequences unique to human miRs, discarding probes for tRNAs, snoRNAs, and misannotated sequences. Quality control analysis and relative quantitation of data generated with TaqMan Arrays were performed using the SDS RQ Manager Software v1.2.1 and the DataAssist Software v3.01
(Cond..) Table 2 . List of primers sequences 5'-3' for RT-qPCR
Primer Sequence
Nkx2.5 fw 5′-ACCCAGCCAAGGACCCTAGA-3' (Applied Biosystems). All Ct values reported as greater than 40 or as not detected were changed to 40 and considered a negative call. Raw expression intensities of target miRs were normalized for differences in the amount of total RNA added to each reaction using the mean expression value of all expressed miRs in a given sample (24) . Relative quantitation of miR expression was performed using the comparative Ct method (∆∆Ct). MiRs were deemed as noninformative and filtered out when the percentile of negative calls exceeded 4 (25 percent of the samples).
MicroRNA profiling data analysis
Differential expression analysis was performed using the module LIMMA (Linear Models for Microarray Data) implemented in the Multi Experiment Viewer (MeV) software package v4.9.0 (25, 26) . Data were log 2 transformed and the two-factor design (tissue and cell type) option was chosen. LIMMA performed the moderated t-statistic for each miR and for each contrast, using an empirical Bayes shrinkage method to borrow information across genes, making the inference about each individual miR stable even for experiments with a small number of arrays. P-values were calculated adjusting for multiple testing using the Benjamini and Hochberg's method to control the false discovery rate (FDR). Adjusted p-values less than 0.05 were considered statistically significant. Unsupervised hierarchical clustering analyses of samples and miRs were performed on log 2 -transformed, meancentered values by Pearson's centered correlation as distance metric and average linkage method, with leaf ordering optimization, using the module implemented in MeV. Experimentally validated miR-target interactions were derived from the databases DNA Intelligent Analysis (DIANA) TarBase v6.0 and miRTarBase Release 4.5 (27, 28) . Functional annotation analysis on validated targets of the differentially expressed miRs was carried out using either the DNA Intelligent Analysis (DIANA) miRPath v2.0 or the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (29, 30) . DIANA miRPath was used to perform gene-enrichment analysis in KEGG pathways; DAVID was used for Gene Ontology (GO) terms (Biological Process and Molecular Function categories). Over-representation statistical analysis was performed by conservative adjustments of Fisher's exact test, followed by Benjamini and Hochberg's correction for FDR. Statistical significance level was set for adjusted p-values less than 0.05. Redundant GO terms were removed using the web-based tool Reduce and Visualize Gene Ontology (REViGO), with an allowed similarity threshold of 0.5 (31).
Statistical analysis
Data were presented as mean ± SD. Statistical analysis was performed using ANOVA or Student t-test when appropriate (see figure/table captions for the test used for each specific experiment). A p-value less than 0.05 was considered statistically significant.
RESULTS
Morphology, immunophenotyping and cardiomyogenic potential of skin and cardiac fetal stromal cells
Fetal stromal cells were isolated as heterogeneous populations from cardiac (CStC) and skin (SStC) fibroblasts of the same aborted fetus of pregnant women between 12 th -16 th week of gestation (n=4 pairs of stromal cells). CStCs and SStCs cultured in GM presented a fibroblast-like morphology, indistinguishable from that of adult stromal cells obtained from skin and right auricle ( Figure 1A ). Both CStCs and SStCs expressed immunophenotypic markers associated with mesenchymal stromal cells, i.e. CD13, CD29, CD44, CD73, and CD105, and were negative for the expression of CD14, CD34, CD45, and HLA-DR ( Figure 1B and Table 3 ). As previously described, CD90 showed a variable expression in the different stromal cell populations and was generally higher in both fetal and adult SStCs than CStCs (Table 3 ) (14, 32) . A higher number of CStCs were positive for CD146 compared to Table 3 ), indicating that a greater proportion of perycytes is present in the fetal cardiac population (33) . We evaluated the ability of CStCs vs SStCs to express cardiomyocyte lineage markers by performing an in vitro assay as previously reported (15) . Specifically, culturing CStCs for 7 days in cardiogenic medium (EpiC medium) significantly increased the protein levels of the cardiac progenitor marker MDR-1, the cardiac mesoderm marker Nkx2.5, and the cardiomyocyte sarcomeric protein alpha-MHC when compared to CStCs expanded in GM ( Figure 1C-D) (15, 16, 34) . In contrast, the same treatment of SStCs only, led to a significant increase in alpha-MHC protein ( Figure 1C-D) . Of note, alpha-MHC expression was significantly higher in Epic-treated CStCs compared to Epic-treated SStCs.
Characterization of iPSCs derived from CStCs vs SStCs
We generated and tested for successful pluripotent reprogramming of iPSC clones from each CStCs and SStCs of the same individual. Three unrelated aborted fetuses were used to create three pairs of skin and cardiac iPSCs. The efficiency of reprogramming (0.002-0.005 percent of transfected cells) is comparable in both SStCs and CStCs. All iPSC clones showed human embryonic stem cell-like morphology and were highly positive for alkaline phosphatase staining (Figure 2A) . RT-qPCR analysis revealed that all iPSC clones expressed endogenous pluripotency genes (SOX2, OCT3/4, Nanog) at significantly higher levels than parental fetal stromal cells (Table 4) . Importantly, all iPSC lines showed no expression of exogenous episomal transgenes, thus confirming successful activation of endogenous pluripotency genes without genomeintegration of exogenous vectors (not shown). Finally, each line expressed the pluripotency markers Oct-4, Nanog, SSEA-4, Tra 1-60, and Tra 1-81 at the protein level ( Figure 2B ). All iPSC clones were able to form embryoid bodies (EBs) and differentiate into cells of the three germ layers, staining positive for ectodermal (Tuj1), Figure 2C ). In addition, most of the endoderm (PDX1, SOX7, and AFP), mesoderm (CD31, ACTA2, SCL, and CDH5) and ectoderm (KTR14, NCAM1, TH, and GABRR2) genes analyzed had significantly up-regulated expression in EBs at day 15-20 of differentiation when compared to undifferentiated iPSCs (Table 5 ) (18).
Efficiency of cardiac differentiation of C-iPSCs vs S-iPSCs
IPSC clones derived from three matching pairs of CStCs and SStCs were differentiated into beating EBs using cardiogenic medium (18, 19) . Spontaneous beating foci started to appear 10 days after starting differentiation for both S-iPSCs and C-iPSCs, and their number gradually increased until reaching a plateau around 18-20 days into differentiation. The number of beating EBs was significantly higher in cultures of C-iPSCs in comparison with S-iPSCs ( Figure 3A) . Also, FACS analysis showed a significant increase in Troponin T (Tn-T) positive cells within EBs obtained from C-iPSCs compared to S-iPSCs ( Figure 3B) . Beating areas were then dissected from beating clusters at day 20-25, to obtain cardiomyocyteenriched preparations for subsequent characterization. Manually dissected beating areas (Beaters) had a diameter ranging from 200 to 500 µm. The dimensions of beating clusters were not significantly different between beating EBs from S-iPSCs and C-iPSCs (not shown). FACS analysis revealed that dissected beating areas are enriched in Tn-T positive cells compared to parental EBs and specifically, that the number of Tn-T positive cells was higher in C-iPSCs dissected beaters compared to S-iPSCs ( Figure 3B ). Both S-Beaters and C-Beaters expressed cardiac specific Troponin I (Tn-I) and alphaActinin organized in a sarcomeric pattern ( Figure 3C ). Further, RT-qPCR analysis showed that the expression levels of early cardiac mesoderm markers (GATA4, Mef2c and Tbx5) were similar between S-and C-Beaters after 30 days of differentiation ( Figure 4A ), while C-Beaters expressed significantly higher Nkx2.5 and cardiomyocyte markers (MYLC2a, alpha-Sarc, alpha-MHC, and beta-MHC) levels than S-Beaters ( Figure 4B) . Additionally, C-Beaters exhibited higher expression than S-Beaters of a specific subset of cardiac ionic channels, namely HCN1, HCN2, HCN4 (responsible for pacemaker channels), CACNA1C and CACNA1G (the alpha-subunits for L-type and T-type calcium channels, respectively) ( Figure 5A ). The expression of HCN3 did not differ between the two populations ( Figure 8A) . Finally, the expression levels of myomiRs (miR-1, -133a, and -133b) are significantly higher in C-Beaters than S-Beaters, while miR-208a did not significantly differ between beaters from the two populations ( Figure 5B ). Figure 6 shows the electrophysiological properties of S-Beaters and C-Beaters. Action potentials of whole beating areas derived from either S-iPSCs or Figure 6A ). The beating rates were similar regardless of the age or the origin of beating clusters ( Figure 6A ; see Table 6 for detailed values). In contrast, 60 day-old C-Beaters displayed significantly more hyperpolarized maximum diastolic potentials (MDPs) and higher action potential (AP) amplitudes when compared to either 30 day-old C-Beaters or 60 day-old S-Beaters ( Figure 6B -C and Table 6 ). These data may suggest a higher degree of electrical maturation of C-Beaters with respect to S-Beaters. S-Beaters demonstrated limited electrical maturation from 30 to 60 days of differentiation in standard cardiogenic medium ( Figure 6B-C) . Furthermore, compared to 30 day-old C-Beaters, 60 day-old C-Beaters showed less increase in beating rate when challenged with a saturating concentration (1 microM) of isoproterenol ( Figure 6D -E), indicating potential maturation toward working cardiomyocytes with less adrenergic response in their automaticity. Of note, evaluating both kinematics and dynamics revealed that C-Beaters after 20-25 days of differentiation were characterized by significantly higher contractility than S-Beaters ( Figure 6F ), whereas, in agreement with patch-clamp recordings, no significant difference was found in terms of contraction frequency (data not shown). © 1996-2016
Functional characteristics of dissected beaters
miR profiling of CStCs vs SStCs and their iPSC counterpart
Potential involvement of miRs in affecting iPSC differentiation was assessed by miR expression profiling on CStCs, SStCs and their iPSC counterparts. After applying quality and filtering criteria, 482 miRs were considered for subsequent analyses. An unsupervised hierarchical clustering analysis, performed on the entire miR profiles of both cardiac and skin stromal cells before and after the reprogramming process, showed that cells clustered together in relation to their state (founder Figure 7A ). This observation suggests that the reprogramming process resulted in extensive modifications of cellular miR expression and likely diminished tissue-specific differences. This is confirmed by the LIMMA analysis, which revealed that 12 miRs appeared differentially expressed between CStCs and SStCs (4 overexpressed and 8 decreased, respectively) at a nominal p-value less than 0.01 ( Figure 7B ), but this difference did not withstand correction for multiple comparisons. This probably reflects a high inter-individual variability in miR expression. Most importantly, these differences in the miR expression profiles between the founder stromal cells was lost after induction of pluripotency, as these miRs did not show any significant differential expression between the iPSC counterparts ( Table 7) . Of note, only 2 miRs were overexpressed in C-iPSCs vs S-iPSCs, at a nominal p-value less than 0.01, but again this did not withstand FDR correction ( Table 7) . The impact of reprogramming on miR expression was further elucidated when we compared fetal stromal cells derived from heart or skin with their reprogrammed iPSC counterpart. LIMMA analysis allowed us to identify 167 miRs significantly modulated by the induction of pluripotency, with a FDR-adjusted p-value less than 0.05. Most of these miRs were similarly modulated in cells both of cardiac and skin origin. Of note, 33 miRs were specifically modulated in cardiac cells, whereas 43 were exclusive for skin cells ( Figure 8 and Table 8 ). Gene-enrichment analysis in KEGG pathways (Table 9) , conducted on validated targets of miRs specifically modulated by reprogramming process in the two cell types, revealed that these miRs may interact both with common (i.e. Akt, p53, cell cycle) and distinct pathways (i.e. VEGF and TGFbeta signaling for cardiac cells, HIF-1 signaling in skin cells). Finally, we performed a gene-enrichment analysis in GO terms for Biological Processes and Molecular Function on validated miR-target interactions, excluding those categories significantly enriched in both cell types after reprogramming. This analysis revealed that miRs modulated in cells of cardiac origin may interact with ribosome biogenesis and metabolism and mRNA stability, ER-nuclear signaling pathways, and cell morphogenesis and differentiation (Table 9) . Interestingly, miRs predicted to target histone deacetylase (HDAC) binding were modulated by the reprogramming process only in cells of atrial origin (Table 9) . Following this line of evidence, we performed Western Blot analysis on two putative target proteins belonging to HDAC binding class, GCN5 and P300/CBP-associated factor (PCAF). Of note, GCN5 protein level was significantly lower in C-iPSCs than in S-iPSCs, whereas PCAF protein level remained unchanged (data not shown). Conversely, our analysis revealed that miRs differentially expressed in skin may target genes involved in cell migration, actin filament-based process, epithelial tube formation, senescence and leukocyte cell-cell adhesion (Table 9 ). This might partially account for the lower cardiogenic potentials of the S-iPSCs.
DISCUSSION
The issue of epigenetic memory in iPSCs is still controversial. Although it has been demonstrated that in murine iPSC lines epigenetic markers of the tissue of origin are evident at early passages (i.e. less than 10), extended passaging (greater than 20-25) of human iPSCs did not increase their resemblance to human embryonic stem cells (5, 35, 36) . This could be interpreted as an incomplete resetting of somatic gene expression and/or epigenetic states in iPSCs, thus underlying the role of the donor epigenetic landscape in determining potential iPSC properties. Consistent with this concept, it has been reported that iPSCs derived from human retinal pigmented epithelial cells (RPE) showed a preferential commitment to spontaneously differentiate back to RPE even after extensive passaging despite being able to give rise to cells of three germlayers (37) .
The present study demonstrated that CStCderived iPSCs at passages greater than 15 retain a higher tendency to generate cardiomyocytes with more mature characteristics than iPSCs obtained from SStCs, supporting for the first time the existence of a functional memory specifically associated with the stromal components of the tissue of origin. The fact that C-Beaters showed a significant enrichment of Tn-T positive cells than S-Beaters, along with the observation that immunofluorescence analysis does not seem to indicate an higher expression of Tn-I and alpha-Actinin in cardiomyocytes obtained from C-iPSCs vs S-iPSCs, seem to support the hypothesis that beaters from C-iPSCs might contain a higher number of cardiomyocytes than dissected beaters from S-iPSCs. In addition, electrophysiological results displayed a more hyperpolarized diastolic potentials and larger action potential amplitudes in C-Beaters compared to S-Beaters, consistent with an increased level of in vitro maturation of cardiomyocytes composing C-Beaters. Finally, measuring kinematics and dynamics demonstrated a higher contractility of C-Beaters vs S-Beaters thus possibly indicating both a higher number and better in vitro maturation of cardiomyocytes in beating syncytia from C-iPSCs.
To exclude that the differences observed in cardiomyogenic differentiation between C-iPSCs and S-iPSCs were related to random clonal events and not to actual epigenetic factors, we generated iPSCs from three independent donors. It is recognized that the variability among different clones obtained from the same individual is lower than the variability among lines from different individuals (38) . Although intrinsic line-to-line variability in differentiation capacity can complicate the interpretation of comparative studies, we observed a clear increase of cardiomyogenic efficiency in all the lines derived from cardiac tissue compared The mean centered value of normalized log 2 transformed relative expression level of each miR is represented with a green, black, and red color scale (green indicates below mean; black, equal to mean; and red, above mean). © 1996-2016 to their skin counterparts. Of note, differentiation protocols based on EB formation show a lower cardiomyogenic efficiency compared to other up-todate optimized protocols using, for example, Activin A, BMP4 or chemical inhibitors of Wnt signaling to push cardiomyogenic differentiation (39) (40) (41) . Nevertheless, we have specifically chosen a standard spontaneous differentiation protocol because the aim of the work was to identify potential differences in cardiomyogenic efficiency between skin and cardiac-derived iPSCs and not to adopt specific measures able to globally increase the cardiomyogenic potential of iPSCs but also potentially capable of abolishing epigenetic-related differences (39) (40) (41) .
The observation that cardiac iPSCs display better cardiogenic properties even though the original stromal cells are not cardiomyocytes strongly supports the hypothesis that stromal cells could actually act as in vivo precursor cells, being able to acquire cardiomyocyte-like properties when exposed to appropriate stimuli (14, 15) . This observation is in line with our recent report showing in a rat model of chronic myocardial infarction that isolated adult cardiac stromal cells shared the same morphology and surface markers to bone marrow stromal cells. Nevertheless adult CStCs displayed superior cardiacspecific properties, such as efficient expression of cardiovascular markers in vitro, and more proficient integration into the myocardial tissue, as well as cardiomyocyte differentiation after in vivo injection, than stromal cells of bone marrow origin (14) . In the present work, we also demonstrated that C-iPSCs exhibit a functional memory of the cardiac muscle even if they are obtained from fetal samples. This observation is extremely important when considering that different authors have hypothesized that iPSCs obtained from fetal samples would not retain the same tissue-specific markers as their adult counterparts. Our findings indicate that the tissue of origin actually influences the differentiation abilities of their iPSCs regardless of the developmental stages of founder stromal cells. Of note, fetal CStCs, similar to adult stromal cells, presented a certain degree of plasticity towards the cardiomyocyte phenotype when proper cardiogenic induction is provided (14) .
The molecular determinants of the observed functional differences between iPSCs from cells of different origin remain to be determined. A major factor is probably the distinct molecular networks activated or repressed in the two cell populations, among which miRs might play a role. Interestingly, we have recently shown that adult cardiac and bone marrow stromal cells exhibit a specific small subset of miRs whose expression remains unmodified after exposure to diverse differentiation stimuli, thus defining a cell-type specific signature (42) . Notably, as previously described for adult stromal cells, also fetal stromal cells exhibited a subset of tissue-specific miRs. Nonetheless, the differences in miR expression observed between fetal CStCs and SStCs were completely abolished by the reprogramming process. However, a deeper analysis revealed that, despite a common core of 91 miRs equally modulated during the pluripotency induction, CStCs and SStCs still displayed 33 and 43 differentially modulated miRs, respectively as an index and a consequence of their specific response to the reprogramming process. Interestingly, KEGG pathway analysis performed on validated targets revealed that the 33 miRs associated with the reprogramming of CStCs specifically target VEGF and TGF-beta pathways. The role of VEGF in cellular processes that are crucial for cardiac development is well known (43) . Also, a recent study demonstrated that VEGF ameliorates the efficiency of differentiation into cardiomyocytes of iPSCs from different somatic origin (44) . Additionally, the TGF-beta pathway has been associated to cardiomyogenic-like differentiation of mesenchymal stem cells (MSCs), to cardiosphere formation and maturation and to enhanced cardiogenic potential (45, 46) . On the other hand, the HIF-1 signaling pathway, known to reduce the number and the maturation of differentiating cardiomyocytes, is specifically targeted by miRs during the reprogramming process of SStCs. Of note, HIF-1 signaling appears to impair cardiogenic differentiation by reducing the number and the maturation of differentiating cardiomyocytes, which might provide a possible explanation of the lower cardiac differentiation capabilities observed in S-iPSCs (47) . Finally, among the commonly targeted pathways, the PI3K/Akt pathway can be involved in the molecular mechanisms regulating cardiomyogenesis specifically by suppressing the GSK-3β activity and (49, 50) . On the other hand, the overexpression of HDAC4 inhibited cardiomyogenesis and downregulated cardiac muscle gene expression (50) . Consistently, higher levels of histone acetylation of H3 and H4 at cardiac-specific gene promoter regions, as well as lower binding levels of HDAC1 and HDAC2, were observed in cardiac stem cells (CSCs) when compared to MSCs, and this reflects a stronger potential for CSCs to develop into cardiomyocytes (51) . In our model, the up-regulation of miR-92a-3p in CStCs during reprogramming is associated with a significant reduction of its validated target GCN5 in C-iPSCs compared to S-iPSCs (52) . Nevertheless, the level of PCAF acetylase remained unchanged in C-and S-iPSCs, probably due the fact that PCAF can be targeted by several miRs whose expression is modulated in both directions. miR92a-3p, -19a-3p, -25-3p, and 106b-5p expression was, in fact, up-regulated, while miR-181a-5p was downregulated during the reprogramming process. Additional experiments are needed to elucidate the mechanistic role of miRs and their targets in determining epigenetic memory in our iPSC model.
Although the molecular mechanisms responsible for this process remain to be characterized in depth, our results support the notion that iPSCs retain a memory of their tissue of origin and, as a consequence, have better cardiac differentiation aptitudes. 
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